Sudarshan Pharma Industries is engaged in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
Sudarshan Pharma is also does outsourcing their manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate.
Sudarshan Pharma has developed expertise in innovation in specialty chemical, bulk drugs, API and pharmaceutical formulation to provide the products having wide application in pharma, paint, food and adhesive industry.
Sudarshan Pharma has launched wide products range in pharma formulation such as Jivan Kit, Setdown, Pulmo relief, Fix Pollen, Flupimac and many more as well as have established goodwill for quality products and have regular clients for the same.
The Company has a Contract Manufacturing Agreement with four pharmaceutical companies and has also joined hands with regular suppliers having FDA and WHO approved plant to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for company’s own brands.
Company’s top clients include Cipla, Larsen & Toubro (Aeronautical division), Berger, Gujarat Insecticides, Huntsman, Navin Flourine Industries, Insecticides India Ltd, Isia (Asia) Agrochemicals Pvt Ltd, SRF Ltd, Clean Science and Technology Pvt Ltd, Songwon Speciality Chemicals-India Pvt. Ltd to name a few.
Sudarshan Pharma has exported to countries like Uzbekistan, Bangladesh, Taiwan, Sultanate of Oman, (Muscat) Dubai, (UAE) & UK. Further, the company has a product pipeline ready for exports in countries like South East Asia, Middle East & North Africa.
Sudarshan Pharma IPO – Details
| IPO Opening Date | 09 March 2023 |
| IPO Closing Date | 14 March 2023 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 68,62,400 Shares Worth ₹50.10 Crore Fresh Issue: 68,62,400 Shares Worth ₹50.10 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹71-₹73 |
| Market Lot | 1600 Shares |
| Min Order1 | 1600 Shares (1 Lot) |
| Listing At | BSE SME |
| Register | KFin Technologies Private Limited |
| QIB Shares Offered | 50% |
| Retail Shares Offered | 35% |
| NII (HNI) Shares Offered | 15% |
Sudarshan Pharma IPO – Date Schedule
| IPO Open Date | 09 March 2023 |
| IPO Close Date | 14 March 2023 |
| Basis of Allotment | 17 March 2023 |
| Initiation of Refunds | 20 March 2023 |
| Credit of Shares to Demat Account | 21 March 2023 |
| IPO Listing Date | 22 March 2023 |
Sudarshan Pharma IPO – Lots Size & Price
| Application | Lots | Shares | Amount ( Cut-Off) |
| Minimum | 1 | 1600 | 1,16,800 |
| Maximum | 1 | 1600 | 1,16,800 |
Competitive Strengths
- Venturing into API manufacturing.
- Focus on increasing the global sales.
- Increasing Operational efficiency.
- Broaden and Deepen Presence in the existing product portfolio.
- Increase by targeting unexplored markets.
- Expand the scope by adding more products.
Company Promoters
- Mr. Hemal Vasantrai Mehta
- Mr. Sachin Vasantrai Mehta
Object Of The Issue
- Working Capital Requirements.
- General Corporate Expenses.
Company Financial
| Particulars | Total Revenue | Total Expense | Profit After Tax |
|---|---|---|---|
| 31 March 2020 | 148.00 | 146.28 | 1.27 |
| 31 March 2021 | 193.72 | 190.15 | 2.67 |
| 31 March 2022 | 357.55 | 350.36 | 5.30 |
| 30 September 2022 | 195.89 | 191.08 | 3.60 |
Sudarshan Pharma IPO Promoter Holding
| Pre Issue Share Holding | 80.28% |
| Post Issue Share Holding |
Sudarshan Pharma IPO Prospectus
Company Contact Information
| Sudarshan Pharma Industries Limited 301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai City Maharashtra 400092 India. Phone: 022- 42221111 Email: compliance@sudarshanpharma.com Website: www.sudarshanpharma.com |
Sudarshan Pharma IPO Registrar
| KFin Technologies Private Limited Phone: +91 40 6716 2222 Email: einward.ris@kfintech.com Website: www.kfintech.com |
Sudarshan Pharma IPO Lead Manager(s)
| 1. Gretex Corporate Services Limited |
Sudarshan Pharma IPO FAQs
| What is Sudarshan Pharma IPO? Sudarshan Pharma IPO is a SME IPO. The issue is priced at ₹71-₹73 per equity share. The IPO is to be listed on BSE SME. |
| When Sudarshan Pharma IPO will open? The IPO is to open on 09 March 2023 for NII and Retail Investors. |
| What is Sudarshan Pharma IPO Investors Portion? The investors portion for QIB- 50%, NII-15%, and Retail-35%. |
| How to Sudarshan Pharma IPO? You can apply Sudarshan Pharma IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Sudarshan Pharma IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Sudarshan Pharma”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Sudarshan Pharma IPO through Edelweiss? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Sudarshan Pharma”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Edelweiss. |
| What is Sudarshan Pharma IPO Size? Sudarshan Pharma IPO size is ₹[] crores. |
| What is Sudarshan Pharma IPO Price Band? Sudarshan Pharma IPO Price Band is ₹71-₹73. |
| What is Sudarshan Pharma IPO Minimum and Maximum Lot Size? The minimum bid is 1600 Shares with ₹1,16,800 amount while the maximum bid is 1600 shares with ₹1,16,800. |
| What is the Sudarshan Pharma IPO Allotment Date? Sudarshan Pharma IPO allotment date is 17 March 2023. |
| What is the Sudarshan Pharma IPO Listing Date? Sudarshan Pharma IPO listing date is 22 March 2023. The IPO is to list on BSE SME. |
